I've thought about it. A company who's financial future is well secured with infinite reverse splits and dilutions? But who is buying if the CTL deal has completely hollowed SINTX out? Death spiral finance shorts? They need an infinite supply of shares to cover with? I think you could just naked short here until your hearts content.
Unless you're "borrowing" the shares you own to develop a supply of shares to "loan" (loan yourself to short.)Too complex to wrap my head around.
A company on the verge of merger acquisition? Key players in one company with key players in another company being installed with the intent to merge the players into a single group?
Just like when they hired Dana and Ryan who were supposed to be the saviors. They diluted after that right? They hired ONE PERSON and that’s supposed to mean some magic is supposed to happen? The pattern is repeating itself
Better question is what do they need much cash for? Once CTL revenue comes in, that should cover a decent portion of G&A. Clinical trial plus some R&D would be about it (R&D is about 4m a year). If clinical trial they'll have a signed agreement in hand first as a clinical trial would be joint effort.
News 
Market Data 
Discover 
